$2500 | Single User
$3000 | Multi User
$4500 | Global License

GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026
[Lowest Price Guaranteed: $2,500]

Published by Inkwood Research: 15 Jan 2018 | 199736 | In Stock
Related Topics: AstraZeneca , Boehringer Ingelheim , DNA Microarray , GlaxoSmithKline , Pfizer , Protein , Roche , Technology

Introduction

KEY FINDINGS

Propelled by factors like the low performance of branded drugs as compared to generic drugs and rising spending on healthcare and research, the global drug discovery market is expected to make a leap of 9.73% CAGR, increasing its revenue from $ 36.7 billion to .6 billion between the forecast years of 2018-2026.

MARKET INSIGHTS

Technology-wise, the global drug discovery market is segmented into Protein Microarrays, QPCR, Mass Spectrometry, DNA Microarrays, High Throughput Screening, Protein and Nucleic Acid Isolation, Gel Electrophoresis, Chromatography, and Other Technologies. Extensive R&D for new product launches can be viewed as major opportunities for the market to expand.

REGIONAL INSIGHTS

North America, Asia-Pacific, Europe and Rest of World are the geographical segments of this market. By the end of the forecast period, the North American market is anticipated to account for the lion's share of the global market. The U.S is expected to be a major contributor to this region, driven by high healthcare spending and growing lifestyle oriented diseases. Also, the Asia-Pacific market is predicted to register the fastest growth driven by high investments and growing R&D.

COMPETITIVE INSIGHTS

Noted players in the global drug discovery market include Bayer Ag, AstraZeneca Plc, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd, Eli Lily, GlaxoSmithKline Llc, Merck & Co. Inc, Sanofi and Pfizer Inc.

Table of Contents
for GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026

  • 1. RESEARCH SCOPE

    1.1. STUDY GOALS

    1.2. SCOPE OF THE MARKET STUDY

    1.3. WHO WILL FIND THIS REPORT USEFUL?

    1.4. STUDY AND FORECASTING YEARS

    2. RESEARCH METHODOLOGY

    2.1. SOURCES OF DATA

    2.1.1. SECONDARY DATA

    2.1.2. PRIMARY DATA

    2.2. TOP DOWN APPROACH

    2.3. BOTTOM-UP APPROACH

    2.4. DATA TRIANGULATION

    3. EXECUTIVE SUMMARY

    3.1. MARKET SUMMARY

    3.2. KEY FINDINGS

    3.2.1. HIGH PREVALENCE RATES OF MAJOR HEALTH DISORDERS

    3.2.2. NORTH AMERICA HAS THE HIGHEST MARKET SHARE

    3.2.3. ASIA PACIFIC IS THE FASTEST GROWING REGION

    3.2.4. IMPLEMENTATION OF DRUG DISCOVERY PROGRAMS

    4. MARKET DETERMINANTS

    4.1. MARKET DRIVERS

    4.1.1. AGING POPULATION

    4.1.2. BRANDED DRUGS ARE OUTPERFORMING DUE TO HIGH COST AS COMPARED TO GENERIC DRUGS

    4.1.3. SPENDING ON HEALTHCARE HAS BEEN INCREASING

    4.1.4. GLOBAL INCREASE IN LIFESTYLE ORIENTED DISEASES & FATALITIES

    4.2. MARKET RESTRAINTS

    4.2.1. GOVERNMENT REGULATIONS DELAYING THE PROCESSES

    4.2.2. DELAY IN PRODUCT LAUNCHES

    4.2.3. POOR ACCESS TO THE HEALTHCARE SERVICES IN DEVELOPING MARKETS

    4.2.4. MARKET IS SHIFTING FROM BRANDED TO GENERIC DRUGS

    4.3. MARKET CHALLENGES

    4.3.1. COST BARRIER FOR LOCAL PEOPLE IN EMERGING ECONOMIES

    4.4. MARKET OPPORTUNITIES

    4.4.1. EXTENSIVE R&D FOR NEW PRODUCT LAUNCHES

    5. MARKET SEGMENTATION

    5.1. MARKET BY TECHNOLOGY 2018-2026

    5.1.1. QPCR

    5.1.2. DNA MICROARRAYS

    5.1.3. PROTEIN MICROARRAYS

    5.1.4. HIGH-THROUGHPUT SCREENING

    5.1.5. MASS SPECTROMETRY

    5.1.6. GEL ELECTROPHORESIS

    5.1.7. CHROMATOGRAPHY

    5.1.8. PROTEIN AND NUCLEIC ACID ISOLATION

    5.1.9. OTHER TECHNOLOGIES

    6. KEY ANALYTICS

    6.1. PORTER’S FIVE FORCES ANALYSIS

    6.1.1. THREATS OF NEW ENTRANTS(LOW)

    6.1.2. COMPETITIVE RIVALRY (HIGH)

    6.1.3. BARGAINING POWER OF BUYERS (MEDIUM)

    6.1.4. BARGAINING POWER OF SUPPLIERS (LOW)

    6.1.5. THREAT OF SUBSTITUTE PRODUCTS (HIGH)

    6.2. VALUE CHAIN ANALYSIS

    6.3. KEY EXCERPTS OF THE STUDY

    6.3.1. RELAXATION IN THE REGULATIONS BY THE GOVERNMENT WHICH STOPS RESEARCHERS FROM DOING RESEARCH.

    6.3.2. MARKET LEADERS SHOULD OPEN UP THEIR BRANCHES AND RESEARCH LABS IN EMERGING MARKETS.

    6.4. PESTLE ANALYSIS

    6.5. OPPORTUNITY MATRIX

    7. GEOGRAPHICAL ANALYSIS

    7.1. NORTH AMERICA

    7.1.1. UNITED STATES (U.S.)

    7.1.2. CANADA

    7.2. EUROPE

    7.2.1. UNITED KINGDOM (UK)

    7.2.2. FRANCE

    7.2.3. GERMANY

    7.2.4. SPAIN

    7.2.5. ITALY

    7.2.6. REST OF EUROPE (ROE)

    7.3. ASIA PACIFIC

    7.3.1. INDIA

    7.3.2. CHINA

    7.3.3. JAPAN

    7.3.4. KOREA

    7.3.5. AUSTRALIA

    7.3.6. REST OF ASIA-PACIFIC (ROAPAC)

    7.4. REST OF THE WORLD (ROW)

    8. COMPANY PROFILES

    8.1. ASTRAZENECA PLC

    8.1.1. COMPANY OVERVIEW

    8.1.2. PRODUCT PORTFOLIO

    8.1.3. SWOT ANALYSIS

    8.1.4. STRATEGIC INITIATIVES

    8.2. BAYER AG

    8.2.1. COMPANY OVERVIEW

    8.2.2. PRODUCT PORTFOLIO

    8.2.3. SWOT ANALYSIS

    8.2.4. STRATEGIC INITIATIVES

    8.3. BOEHRINGER INGELHEIM

    8.3.1. COMPANY OVERVIEW

    8.3.2. PRODUCT PORTFOLIO

    8.3.3. SWOT ANALYSIS

    8.4. ELI LILY

    8.4.1. COMPANY OVERVIEW

    8.4.2. PRODUCT PORTFOLIO

    8.4.3. SWOT ANALYSIS

    8.4.4. STRATEGIC INITIATIVES

    8.5. F. HOFFMANN-LA ROCHE LTD

    8.5.1. COMPANY OVERVIEW

    8.5.2. PRODUCT PORTFOLIO

    8.5.3. SWOT ANALYSIS

    8.5.4. STRATEGIC INITIATIVES

    8.6. GLAXOSMITHKLINE LLC

    8.6.1. COMPANY OVERVIEW

    8.6.2. PRODUCT PORTFOLIO

    8.6.3. SWOT ANALYSIS

    8.6.4. STRATEGIC INITIATIVES

    8.7. JOHNSON AND JOHNSON

    8.7.1. COMPANY OVERVIEW

    8.7.2. PRODUCT PORTFOLIO

    8.7.3. SWOT ANALYSIS

    8.7.4. STRATEGIC INITIATIVES

    8.8. MERCK & CO. INC.

    8.8.1. COMPANY OVERVIEW

    8.8.2. PRODUCT PORTFOLIO

    8.8.3. SWOT ANALYSIS

    8.8.4. STRATEGIC INITIATIVES

    8.9. PFIZER, INC.

    8.9.1. COMPANY OVERVIEW

    8.9.2. SWOT ANALYSIS

    8.9.3. STRATEGIC INITIATIVES

    8.10. SANOFI

    8.10.1. COMPANY OVERVIEW

    8.10.2. PRODUCT PORTFOLIO

    8.10.3. SWOT ANALYSIS

    8.10.4. STRATEGIC INITIATIVES

    TABLE LIST

    TABLE 1 GLOBAL DRUG DISCOVERY MARKET BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 2 FACT SHEETS OF GLOBAL FATALITIES

    TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2018-2026

    TABLE 4 GLOBAL DRUG DISCOVERY MARKET IN QPCR BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 5 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 6 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS, BY GEOGRAPHY 2018-2026(IN $MILLION)

    TABLE 7 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING, BY GEOGRAPHY 2018-2026(IN $MILLION)

    TABLE 8 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 9 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS, BY GEOGRAPHY 2018-2026, (IN $MILLION)

    TABLE 10 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 11 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 12 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    TABLE 14 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

    TABLE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    TABLE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE LIST

    FIGURE 1 GLOBAL DRUG DISCOVERY MARKET 2018-2026 (IN $MILLION)

    FIGURE 2 GLOBAL DRUG DISCOVERY MARKET IN QPCR 2018-2026 (IN $MILLION)

    FIGURE 3 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS 2018-2026 (IN $MILLION)

    FIGURE 4 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS 2018-2026 (IN $MILLION)

    FIGURE 5 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING 2018-2026 (IN $MILLION)

    FIGURE 6 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY 2018-2026 (IN $MILLION)

    FIGURE 7 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS 2018-2026 (IN $MILLION)

    FIGURE 8 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY 2018-2026 (IN $MILLION)

    FIGURE 9 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION 2018-2026 (IN $MILLION)

    FIGURE 10 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES 2018-2026 (IN $MILLION)

    FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

    FIGURE 12 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

    FIGURE 13 UNITED STATES DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

    FIGURE 14 CANADA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 16 UNITED KINGDOM DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 17 FRANCE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 18 GERMAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 19 SPAIN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 20 ITALY DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 21 REST OF EUROPE (ROE) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 22 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 23 INDIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 24 CHINA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 25 JAPAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 26 KOREA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 27 AUSTRALIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 28 REST OF ASIA-PACIFIC (ROAPAC) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

    FIGURE 29 REST OF THE WORLD (ROW) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

List Of Tables
in GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026

TABLE LIST

TABLE 1 GLOBAL DRUG DISCOVERY MARKET BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 2 FACT SHEETS OF GLOBAL FATALITIES

TABLE 3 GLOBAL DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2018-2026

TABLE 4 GLOBAL DRUG DISCOVERY MARKET IN QPCR BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 5 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 6 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS, BY GEOGRAPHY 2018-2026(IN $MILLION)

TABLE 7 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING, BY GEOGRAPHY 2018-2026(IN $MILLION)

TABLE 8 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY, BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 9 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS, BY GEOGRAPHY 2018-2026, (IN $MILLION)

TABLE 10 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY, BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 11 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION, BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 12 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 13 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

TABLE 14 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

TABLE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

TABLE 16 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

List Of Figures, Charts and Diagrams
in GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026

FIGURE LIST

FIGURE 1 GLOBAL DRUG DISCOVERY MARKET 2018-2026 (IN $MILLION)

FIGURE 2 GLOBAL DRUG DISCOVERY MARKET IN QPCR 2018-2026 (IN $MILLION)

FIGURE 3 GLOBAL DRUG DISCOVERY MARKET IN DNA MICROARRAYS 2018-2026 (IN $MILLION)

FIGURE 4 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN MICROARRAYS 2018-2026 (IN $MILLION)

FIGURE 5 GLOBAL DRUG DISCOVERY MARKET IN HIGH THROUGHPUT SCREENING 2018-2026 (IN $MILLION)

FIGURE 6 GLOBAL DRUG DISCOVERY MARKET IN MASS SPECTROMETRY 2018-2026 (IN $MILLION)

FIGURE 7 GLOBAL DRUG DISCOVERY MARKET IN GEL ELECTROPHORESIS 2018-2026 (IN $MILLION)

FIGURE 8 GLOBAL DRUG DISCOVERY MARKET IN CHROMATOGRAPHY 2018-2026 (IN $MILLION)

FIGURE 9 GLOBAL DRUG DISCOVERY MARKET IN PROTEIN AND NUCLEIC ACID ISOLATION 2018-2026 (IN $MILLION)

FIGURE 10 GLOBAL DRUG DISCOVERY MARKET IN OTHER TECHNOLOGIES 2018-2026 (IN $MILLION)

FIGURE 11 GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY 2018-2026 (IN $MILLION)

FIGURE 12 NORTH AMERICA DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

FIGURE 13 UNITED STATES DRUG DISCOVERY MARKET, 2018-2026 (IN $ MILLION)

FIGURE 14 CANADA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 15 EUROPE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 16 UNITED KINGDOM DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 17 FRANCE DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 18 GERMAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 19 SPAIN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 20 ITALY DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 21 REST OF EUROPE (ROE) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 22 ASIA-PACIFIC DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 23 INDIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 24 CHINA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 25 JAPAN DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 26 KOREA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 27 AUSTRALIA DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 28 REST OF ASIA-PACIFIC (ROAPAC) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

FIGURE 29 REST OF THE WORLD (ROW) DRUG DISCOVERY MARKET, 2018-2026 (IN $MILLION)

Additional Details

Publisher

Inkwood Research

Publisher Information

Inkwood Research's complete end-to-end spectrum of consulting and advisory service offerings driven by subject matter experts provide a comprehensive, research-based view crucial for overcoming market challenges that are not only sustainable over the long-term, but ones that truly drive growth upwards. Inkwood looks at a plethora of data points from diverse sources to show client: customer-centric value proposition ..…

Reference

199736 | 13150

Number of Pages

140

Report Format

PDF

Inkwood Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Orphan Drug Commercial Models: Sustaining the rare disease business
IntroductionChoosing the right commercial model for orphan drug successThe societal and commercial a...
01 May 2016 by FirstWord Pharma USD $695 More Info
Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
IntroductionThe pay for performance agenda gathers pace as US payers rebel the cost of drugs.Pharma ...
01 Mar 2016 by FirstWord Pharma USD $695 More Info
Innovations in Drug Pricing and Reimbursement (2016)
IntroductionIs the drug pricing bubble about to burst?Drug costs are becoming unaffordable and draco...
01 Feb 2016 by FirstWord Pharma USD $2,195 More Info
Drug Delivery - Innovations, trends, and their impact on pharma
IntroductionWhy you need Drug Delivery - Innovations, trends, and their impact on pharmaRevolutionar...
01 Nov 2015 by FirstWord Pharma USD $2,195 More Info
Physician Views: Which companies excel in diabetes drug marketing and why?
Scope With both the insulin and non-insulin segments of the diabetes market expected to become more ...
01 May 2015 by FirstWord Pharma USD $695 More Info
Trends and Innovations in Drug Pricing
IntroductionFirstWord’s Trends and Innovations in Drug Pricing report dissects international trends ...
01 Jan 2015 by FirstWord Pharma USD $695 More Info
Orphan Drug Market Access: Payer Insights on the Present and Future
IntroductionOrphan Drug Market Access: Payer Insights on the Present and Future is a report that exa...
14 Oct 2014 by FirstWord Pharma USD $695 More Info
Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?
Scope While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents ha...
04 Aug 2014 by FirstWord Pharma USD $695 More Info
Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $695 More Info
Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
01 Jun 2013 by FirstWord Pharma USD $695 More Info

This report is published by Inkwood Research

Inkwood Research's complete end-to-end spectrum of consulting and advisory service offerings driven by subject matter experts provide a comprehensive, research-based view crucial for overcoming market challenges that are not only sustainable over the long-term, but ones that truly drive growth upwards. Inkwood looks at a plethora of data points from diverse sources to show client: customer-centric value proposition ..…

Download Free Report Summary PDF

GLOBAL DRUG DISCOVERY MARKET FORECAST 2018-2026 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...